This article is more than 5 years old. Information may no longer be current.

VIDEO: Determination often required to obtain PCSK9 inhibitors for appropriate patients

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BOSTON — In this video exclusive, Matthew Stryker, PharmD, a clinical pharmacist who runs a free cardiovascular risk reduction service at a clinic in Albany, New York, and is a stakeholder in The Doctor-Patient Rights Project, relates a personal story of seeking prior authorization for the PCSK9 inhibitor alirocumab for a statin-intolerant patient with familial hypercholesterolemia.

Only after a fourth appeal with a federal appeals judge was the patient able to obtain the medication. Stryker describes additional resources for prescribers in the appeals process after receiving denial of an original request.